We investigate neural mechanisms of isolated focal dystonia and tremor to determine the disorder-specific pathophysiology and develop novel diagnostic tools and therapeutic strategies for these patients. We use a variety of experimental approaches, including multimodal neuroimaging, advanced machine learning, clinical-behavioral testing, neuropathology, and genetics.
Explore our website to learn more about our research, discoveries, and team.
The Dystonia and Speech Motor Control Laboratory is supported by the National Institutes of Health - National Institute on Deafness and Other Communication Disorders (NIDCD) and National Institute of Neurological Disorders and Stroke (NINDS), Department of Defense, Amazon Web Services, Jazz Pharmaceuticals, Mass General Brigham Innovation.
Recent Publications
- Sensory processing in the auditory and olfactory domains is normal in laryngeal dystonia January 14, 2023
- DystoniaBoTXNet: Novel Neural Network Biomarker of Botulinum Toxin Efficacy in Isolated Dystonia November 28, 2022
- Multimodal collaborative brain-computer interfaces aid human-machine team decision-making in a pandemic scenario September 30, 2022
- Brain-Computer Interfaces for Treatment of Focal Dystonia August 10, 2022
- Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia June 28, 2022
Dystonia and Speech Motor Control Laboratory | Department of Otolaryngology-Head & Neck Surgery, Massachusetts Eye and Ear and Harvard Medical School | 243 Charles Street, Suite 421 | Boston, MA 02114 | 